Skip to contentP
Petmed Express Inc
P
PETSPetmed Express Inc Q3 2023 · 10-Q
Revenue$57.24M$57.24M−5.7% vs Q3 2022 Net Income-$212.00K-$212.00KN/M vs Q3 2022 EPS Diluted-$0.01-$0.01N/M vs Q3 2022 Gross Profit$16,572,000−6.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Petmed Express Inc · CIK 1040130 · Engraved from SEC EDGAR
Operating Cash Flowderived$12,971,000+49.0% Free Cash Flowderived$11,978,000+42.4% Margins · derivedGross margin29.0%−0.2 pt vs Q3 2022
Operating margin-1.3%−9.8 pt vs Q3 2022
Net margin-0.4%−7.4 pt vs Q3 2022
ended Dec 31, 2022 · filed Feb 7, 2023 · 38 d after period end